bullish
Celltrion and Celltrion Health Placement - Past Deals Have Been Mixed
339 Views21 Mar 2022 17:32
Temasek aims to raise around US$450m+ via selling 1.7% of Celltrion Inc (068270 KS) and Celltrion Healthcare (091990 KS) each.
SUMMARY
(Sign Up to Access)Get started on the Smartkarma Research Network with a complimentary Preview Pass to:
- Unlock all research summaries
- Follow top, independent analysts
- Receive personalised alerts and emails
- Access Briefings, Analytics, and Events
Upgrade anytime to our paid plans for full-length research, real-time analyst discussions, and more.
Join a thriving community of 45,000+ investors, including the top global asset managers managing over $13trn in assets.
or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 6-minute read)
Discussions
(Paid Plans Only)
Price Chart(Sign Up to Access)
- Another Block Deal Sale of Samsung SDS by the Lee Family to Pay for Inheritance Taxes30 Mar 2023
- Samsung SDS Placement - Well Flagged and the Last One Did Well30 Mar 2023
- Samsung SDS Placement - Deal Is Very Well Flagged and the Stock Is Cheap, but It's a Tough One21 Mar 2022
- Celltrion and Celltrion Health Placement - Past Deals Have Been Mixed21 Mar 2022
- Celltrion+Celltrion Healthcare Placement- Discount Looks Enticing but the Deal Appears Opportunistic01 Apr 2020
- Celltrion & Celltrion Healthcare Placement - Spread Should Narrow as Inclusion Draws Closer06 Mar 2018
x